Aptinyx discovers and develops
innovative therapies for
challenging disorders of the brain and
nervous system.

nerve 650

Our proprietary compounds modulate
the NMDA receptor,
a critical regulator
involved in nerve cell
communication.

We seek to leverage our experience and
track record of success to rapidly advance
promising therapies into clinical
development for patients in need.